You are here

Article Text

Article menu
Download PDFPDF
Letter
Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema
  1. S D M Chen,
  2. J Lochhead,
  3. B McDonald,
  4. C K Patel
  1. Oxford Eye Hospital, Oxford, UK
  1. Correspondence to: S Chen Oxford Eye Hospital, Woodstock rd, Oxford OX2 6HE, UK; s-chenrocketmail.com

https://doi.org/10.1136/bjo.2003.033589

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Intravitreal triamcinolone injection is a safe and effective treatment for cystoid macular oedema (CMO) caused by uveitis,1 diabetic maculopathy,2 central retinal vein occlusion,3 and pseudophakic CMO.4 Potential risks include glaucoma, cataract, retinal detachment, and endophthalmitis.

    We present a case of pseudohypopyon and sterile endophthalmitis following intravitreal triamcinolone injection for the treatment of pseudophakic CMO.

    Case report

    An 88 year old woman underwent phacoemulsification surgery which was complicated by posterior capsule rupture. Anterior vitrectomy with implantation of a silicone intraocular lens into the sulcus was performed. Postoperatively, CMO developed. This failed to respond to treatment with topical dexamethasone, topical ketorolac, and posterior sub-Tenon triamcinolone injection, limiting visual acuity to 6/24 at 7 months following the cataract surgery.

    An intravitreal injection of triamcinolone acetonide (4 …

    View Full Text